Dr. Lovejoy’s translational research focuses on the design, rigorous testing, and implementation of clinical and health services interventions that improve health of persons living with chronic illnesses, as well as the communities to which they belong. His current research examines multifaceted treatment approaches for the management of chronic pain in patients with co-morbid substances use disorders, as well as telehelath approaches to improve mental health functioning and reduce HIV transmission risk behavior in persons living with HIV.
Areas of interest
- Health Psychology
- Behavioral Medicine
- Substance Use Disorders
- Chronic Pain
- B.A., Whitman College, Walla Walla Washington 2001
- M.P.H., Ohio University, Athens Ohio 2009
- Ph.D., Ohio University, Athens Ohio 2011
- 2010-2011, Psychology Intern, VA Portland Health Care System, Portland, OR
- 2011-2012, Health Psychology Postdoctoral Fellow, VA Portland Health Care System, Portland, OR
Honors and awards
- NIH/OBSSR Randomized Behavioral Clinical Trials Fellow, 2014
- NIH/VACO Training Institute for Dissemination and Implementation Research in Health Fellow, 2013
- NIH Advanced Training Institute on Health Behavior Theory Fellow, 2012
Memberships and associations
- American Psychological Association, Member
- Society for Health Psychology, Member
- AIDS and Behavior, Editorial Board
McPherson S, Lederhos Smith C, Dobscha SK, Morasco BJ, Demidenko MI, Meath THA, LovejoyTI. Changes in pain intensity following discontinuation of long-term opioid therapy for chronic non-cancer pain. Pain. Epub Ahead of Print [June 13, 2018]. doi: 10.1097/j.pain.0000000000001315.
Lovejoy TI, Morasco BJ, Demidenko MI, Meath THA, Dobscha SK. Clinician referrals for non-opioid pain care following discontinuation of long-term opioid therapy differ based on reasons for discontinuation. J Gen Intern Med. 2018;33:24-30. doi: 10.1007/s11606-018-4329-6.
Nugent SM, Dobscha SK, Morasco BJ, Demidenko MI, Meath THA, Frank JW, Lovejoy TI. Substance use disorder treatment following clinician-initiated discontinuation of long-term opioid therapy resulting from an aberrant urine drug test. J Gen Intern Med. 2017;32:1076-1082. DOI: 10.1007/s11606-017-4084-0.
Frank JW, Lovejoy TI, Becker WC, Morasco BJ, Koenig CJ, Hoffecker L, Dischinger HR, Dobscha SK, Krebs EE. Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review. Ann Intern Med. 2017;167:181-191. DOI: 10.7326/M17-0598
Demidenko MI, Dobscha SK, Morasco BJ, Meath THA, Ilgen MA, Lovejoy TI. Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users. Gen Hosp Psychiatry. 2017;47:29-35. https://doi.org/10.1016/j.genhosppsych.2017.04.011
Lovejoy TI, Morasco BJ, Demidenko MI, Meath THA, Frank JW, Dobscha SK. Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. Pain. 2017;158:526-534. DOI: 10.1097/j.pain.0000000000000796
Choo EK, Feldstein Ewing SW, Lovejoy TI. Opiates out, cannabis in: negotiating the unknowns in patient care for chronic pain. JAMA. 2016;316:1763-1764. DOI: 10.1001/jama.2016.13677.
Lovejoy TI, Heckman TG, Sikkema KJ, Hansen NB, Kochman A. Changes in sexual behavior of HIV-infected older adults enrolled in a clinical trial of standalone group psychotherapies targeting depression. AIDS Behav. 2015;19:1-8. DOI 10.1007/s10461-014-0746-7
Lovejoy TI. Telephone-delivered motivational interviewing targeting sexual risk behavior reduces depression, anxiety, and stress in HIV-positive older adults. Ann Behav Med. 2012;44:416-421. DOI: 10.1007/s12160-012-9401-6
Lovejoy TI, Heckman TG, Suhr JA, Anderson T, Davantes Heckman B, France CR. Telephone-administered motivational interviewing reduces risky sexual behavior in HIV-positive late middle-age and older adults: a pilot randomized controlled trial. AIDS Behav. 2011;15:1623-34. DOI: 10.1007/s10461-011-0016-x